Racial differences in PSA screening interval and stage at diagnosis
- PMID: 20333462
- PMCID: PMC2883656
- DOI: 10.1007/s10552-010-9535-4
Racial differences in PSA screening interval and stage at diagnosis
Abstract
Objectives: This study examined PSA screening interval of black and white men aged 65 or older and its association with prostate cancer stage at diagnosis.
Methods: SEER-Medicare data were examined for 18,067 black and white men diagnosed with prostate cancer between 1994 and 2002. Logistic regression was used to assess the association between race, PSA screening interval, and stage at diagnosis. Analysis also controlled for age, marital status, comorbidity, diagnosis year, geographic region, income, and receipt of surgery.
Results: Compared to whites, blacks diagnosed with prostate cancer were more likely to have had a longer PSA screening interval prior to diagnosis, including a greater likelihood of no pre-diagnosis use of PSA screening. Controlling for PSA screening interval was associated with a reduction in blacks' relative odds of being diagnosed with advanced (stage III or IV) prostate cancer, to a point that the stage at diagnosis was not statistically different from that of whites (OR=1.12, 95% CI=0.98-1.29). Longer intra-PSA intervals were systematically associated with greater odds of diagnosis with advanced disease.
Conclusions: More frequent or systematic PSA screening may be a pathway to reducing racial differences in prostate cancer stage at diagnosis, and, by extension, mortality.
References
-
- American Cancer Society . Cancer facts & figures 2009. American Cancer Society; Atlanta: 2009.
-
- American Cancer Society . Cancer facts and figures for African Americans, 2009-10. American Cancer Society; Atlanta: 2009.
-
- Institute of Medicine . Unequal treatment: confronting racial and ethnic disparities in healthcare. National Academies Press; Washington DC: 2003. - PubMed
-
- Institute of Medicine . The unequal burden of cancer: as assessment of NIH research and programs for ethnic minorities and the medically underserved. National Academies Press; Washington DC: 1999. - PubMed
-
- Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198–1205. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 PC035136/CA/NCI NIH HHS/United States
- N01-PC-35139/PC/NCI NIH HHS/United States
- #U55/CCR921930-02/PHS HHS/United States
- PC060224/PC/NCI NIH HHS/United States
- R24 HS013353/HS/AHRQ HHS/United States
- C06 RR020139/RR/NCRR NIH HHS/United States
- R01 CA124402/CA/NCI NIH HHS/United States
- N01-PC-35136/PC/NCI NIH HHS/United States
- PC040907/PC/NCI NIH HHS/United States
- #C06 RR020139/RR/NCRR NIH HHS/United States
- N02 PC015105/PC/NCI NIH HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- U01 CA114629/CA/NCI NIH HHS/United States
- P60 MD000239/MD/NIMHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
